Uppsala Monitoring Centre

04/12/2025

Pharmacists play a central role in and promoting the safety of medicines.

In the latest print issue of , Luxembourg🇱🇺 shares how they've actively partnered with community and hospital pharmacists as ambassadors to raise awareness of ADR reporting and build a sustainable medicines safety culture that extends beyond the campaign week.

Anne-Cécile Vuillemin shares her tips for collaboration in this article 👉 https://ow.ly/wm6850XBInr

Ministère de la Santé et de la Sécurité sociale Luxembourg

03/12/2025

Transparency and reproducibility are key to high-quality research. Broader access to tools, methods, and open-source platforms can support this work and increase collaboration.

In May 2025, Valentina Giunchi, Daniele Sartori, Judith Brand, Niklas Norén, and Michele Fusaroli explored community perspectives on access to open-source methods in pharmacovigilance, including interest in UMC methods and varying programming languages, via a community survey.

Learn about the results of their survey in this new research poster presented at the NorPEN conference 👉 https://ow.ly/8Jkc50XB7V3

02/12/2025

Despite investments to support the development and analysis of real-world evidence, many pharmacovigilance organisations still rely primarily on individual case reports and pre-existing evidence during signal management.

A new report funded and endorsed by ISPE, and featuring contributions from UMC's Niklas Norén, presents a set of recommendations to enable the broader use of real-world evidence throughout signal management. Learn how streamlined data access, data harmonization, reproducible analytical workflows, and more may assist in the future use of RWE for pharmacovigilance decision-making.

at the link below👇
https://onlinelibrary.wiley.com/doi/10.1002/pds.70231

01/12/2025

Substandard and falsified (SF) medicines threaten millions of people worldwide. Yet, significant gaps in knowledge and practice regarding SF medicines leave this problem largely invisible.

Alem Zekarias and Lubna Merchant, with contributions from Saifuddin Ahmed, outline how strengthening systems, harnessing innovative technologies, and investing in comprehensive education can help address the global threat of SF medicines.

📖 Read to learn more 👉 https://ow.ly/UtkH50XzS7V

01/12/2025

📆 Have you registered for the ?

This year's seminar is a hybrid event, and online registration is now open. Join ISoP Online, speakers, and fellow attendees from 4–5 December 2025 as they explore how to build trustworthy in .

Register to attend virtually now 👉 https://isoponline.org/training/seminar/isop-seminar-2025-registration/

Learn more about the event in the post below 👇

📢 is now a hybrid event! 💻 📍 The ISoP Boston Seminar 2025 will now be accessible both in person and online, allowing even more members of the global pharmacovigilance community to participate.

🌎 Whether you plan to join us in Cambridge or attend virtually, you can now register for the online option and be part of the full scientific programme — including all AI-focused sessions, expert discussions, and live interactions.

🌐 Register now for online participation: https://isoponline.org/training/seminar/isop-seminar-2025-registration/

We look forward to welcoming you wherever you are!

28/11/2025

Although has concluded, we are still amazed by the incredible initiatives led by participants this year!

From hospital outreach, television segments, interactive games, tree planting, and more, there was no shortage of creative and inspiring activities to follow online and in person.

This year's 10th anniversary campaign brought together 132 organisations from 118 countries sharing materials in 62 languages – making 2025 our largest to date!

Thank you to all participants, planning team members, and YOU for helping us raise awareness of and show that we all have the power to make medicines safer by reporting side effects.

💬 What was your favourite moment from ? Let us know in the comments below👇

28/11/2025

Scientific and therapeutic interest in such as psilocybin and L*D has grown rapidly over the past decade, while recreational use continues in unregulated settings.

Online psychedelic forums such as hold untapped safety data, hosting thousands of first-person narratives of users' experiences. Ahmed Al-Imam, Manal Mohammed Younus, and Michal Michalak detail how analysis of user narratives could help systems detect risks missed by traditional reporting in .

Read their article at the link below👇

Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.

27/11/2025

🎥 In the past decade, Brazil🇧🇷 has made major developments to its system in partnership with WHO and UMC.

This Autumn, a UMC delegation travelled to Brazil to participate in pharmacovigilance activities in Brasília and São Paulo, working closely with Anvisa. A new film in the WHO PIDM in Focus series will explore the public health system and regulatory aspects of pharmacovigilance in Brazil, showcasing the expanded use of and the implementation of for standardisation.

Watch the sneak preview below👇 and explore the rest of the film series here 👉 ow.ly/j81o50QPVtJ

27/11/2025

We're thrilled to join COFEPRIS for the XIX National Pharmacovigilance and Technovigilance Meeting in Mexico🇲🇽.

📺 Watch the recording of the opening session here: https://fb.watch/DE6VvQ9i0b/

26/11/2025

We go behind the scenes of transforming a campaign into a local movement in the latest print issue of 📖

Hadir Rostom and Mohamed A. Elhawary tell us how harnessing the power of students and university collaborations has expanded in-person activities and boosted engagement with Egypt's campaign.

Read their story 👉 https://ow.ly/X39L50XxsT3

ISoP 2025 Cairo

26/11/2025

It was non-stop action during the CHaSE career fair at Karolinska Institutet in Stockholm🇸🇪 as numerous students and professionals stopped by our booth to learn more about UMC. We had a fantastic time engaging with everyone and sharing how they can apply their skills in the life sciences and medicine in the pursuit of patient safety and pharmacovigilance.

Learn more about our current opportunities for students 👉 https://ow.ly/toB250Qcvlu

25/11/2025

Our Digital Services & Solutions department recently hosted the Innovation and Exploration Days at UMC, a time for creativity, curiosity, and collaboration. Over the course of three days, colleagues from several teams came together to share new product ideas, build prototypes, and explore new tools, methods, and technologies; from to and internal knowledge access.

We look forward to seeing how the insights from this cross-collaboration event translate into impactful solutions 💡